Intellectual Property Patents

  • Qualcomm on Dec. 10 said it had won a preliminary court order in China banning Apple from selling some older iPhone models that the court found violated two Qualcomm software patents. The same day, Apple said that all of its phones remained on sale in China. Apple never publicly commented last week on why or how it believed its current iPhones for sale in China...

  • *Apple says ban unjustified, to hurt China suppliers- document. SHANGHAI/ SAN FRANCISCO, Dec 14- Apple Inc, facing a court ban in China on some of its iPhone models over alleged infringement of Qualcomm Inc patents, said on Friday it will push software updates to users in a bid to resolve potential issues. "Based on the iPhone models we offer today in China, we believe we...

  • SHANGHAI/ SAN FRANCISCO, Dec 14- Apple Inc, facing a court ban in China on some of its iPhone models over alleged infringement of Qualcomm Inc patents, said on Friday it will push software updates to users in a bid to resolve potential issues. "Based on the iPhone models we offer today in China, we believe we are in compliance," Apple said. Qualcomm has said that the Fuzhou...

  • Sanofi is heavily reliant on Lantus, its leading product with sales of 4.62 billion euros in 2017, and Mylan's own insulin drug would be its second competitor after Eli Lilly launched its version in late 2016.. "The PTAB decision alone does not affect the existing 30- month stay and Mylan does not have tentative Food and Drug Administration approval for its...

  • Dec 13- Qualcomm Inc is asking courts in China to ban sales of Apple Inc's latest iPhone models XS and XR after winning a preliminary injunction against older models, the Financial Times reported on Thursday. On Monday, A Chinese court had ordered a sales ban of some older Apple iPhone models for violating two patents of Qualcomm, though intellectual property...

  • Dec 13- Mylan N.V. said on Thursday the U.S. Patent and Trademark Office invalidated French drug company Sanofi's formulation patents on its blockbuster insulin drug Lantus, ruling in favor of the U.S. drugmaker. In October 2017, Sanofi initiated patent infringement litigation against Mylan in a New Jersey court.

  • SAN FRANCISCO, Dec 10- A Chinese court has ordered a ban on the sale of several older Apple Inc iPhone models in China for violating two patents of chipmaker Qualcomm Inc, although Apple said all of its phone models remained on sale in the mainland. Qualcomm said the Fuzhou Intermediate Peoples Court in China found Apple infringed two patents held by the chipmaker...

  • Dec 10- Chip supplier Qualcomm Inc said on Monday it had won an order from a Chinese court banning the sale of several older Apple Inc iPhone models in China because of two patent violations, although Apple said its phones remained on sale. It is not clear what the ruling means for phones with Apple's newer operating system, and Apple said all iPhone models remained...

  • Dec 10- Chip supplier Qualcomm Inc on Monday said it had won a preliminary order from a Chinese court banning the sale of several older Apple Inc iPhone models in China due to two patent violations around software features, though Apple said its phones remain available in the country. It is not clear what the ruling means for phones with Apple's newer operating...

  • Dec 10- Chip supplier Qualcomm Inc on Monday said it had won a preliminary order from a Chinese court banning the sale of several Apple Inc iPhone models in China due to two patent violations around software features, though Apple said its phones remain available in the country. Qualcomm, the biggest supplier of chips for mobile phones, filed its case in China in...

  • WASHINGTON, Dec 4- U.S. Supreme Court justices on Tuesday grappled with a Swiss pharmaceutical company's effort to salvage a patent behind its lucrative anti-nausea drug in a case that could make it easier to cancel key patents, especially among smaller drugmakers. The justices asked tough questions of both sides during an hour of oral arguments in an appeal by...

  • Britain's GW Pharmaceuticals Plc, which recently brought to market a drug derived from marijuana for epilepsy, is now seeking patent protection for another one to treat eczema. With marijuana now fully legal in Canada and at least partially legalized in the majority of U.S. states, companies are rushing to patent new formulations of the age-old botanical.

  • LONDON, Nov 14- Pfizer lost the final round in a lengthy patent battle in Britain on Wednesday after the country's highest court ruled against it in a case involving its $5 billion- a-year pain drug Lyrica, exposing the company to possible financial claims. The Supreme Court decision is a blow for the U.S. drugmaker-- which had sought to affirm a secondary medical use...

  • LONDON, Nov 14- Pfizer lost the final round in a long-running patent battle in Britain on Wednesday after the country's highest court ruled against it in a case involving its $5 billion- a-year pain drug Lyrica. The Supreme Court decision is a blow for the U.S. drugmaker-- which had sought to affirm a secondary medical use patent for the product-- and a win for generic...

  • BERLIN, Nov 2- U.S. semiconductor supplier Broadcom has made a patent claim for more than $1 billion against Volkswagen and is threatening to seek a judicial ban on the production of several car models, German magazine Der Spiegel said on Friday. A Volkswagen spokesman on Friday told Reuters that a legal action had been filed by Broadcom against the German...

  • Oct 26- Qualcomm Inc said in a court hearing on Friday that Apple Inc is $7 billion behind in patent royalty payments to the mobile chip firm, which for years supplied parts for the iPhone. Apple and Qualcomm are involved in a series legal actions. Qualcomm made its comments about the size of Apple's unpaid royalties in a hearing in one of the cases in federal court in...

  • The U.S. Court of Appeals for the Federal Circuit said it agreed with a March 2017 ruling by the Patent Trial and Appeal Board that freed Biogen from future royalty payments to Forward. Biogen's Tecfidera exclusivity in the United States is secured through 2028 under the ruling. In January 2017, Biogen took out an insurance policy against a potential defeat in...

  • Elon Musk, chairman and chief executive officer of Tesla Motors

    Tesla CEO Elon Musk teased a Tesla-branded tequila earlier this year as part ruse on Instagram. Now the company has officially filed an application with the U.S. Patent and Trademark Office to trademark "Teslaquila."

  • Oct 12- A U.S. appeals court on Friday upheld a ruling that canceled patents owned by Teva Pharmaceutical Industries Ltd on its blockbuster multiple sclerosis drug Copaxone.

  • LONDON, Oct 4- Juul Labs, the e-cigarette maker at the heart of a U.S. crackdown on youth vaping, has filed patent infringement complaints in the United States and Europe against what it said were copycat rivals. Juul, which controls nearly three quarters of the U.S. e-cigarette market, filed a complaint on Wednesday with the U.S. International Trade Commission...